*<p>denotes p-value<0.05 relative to a random test (AUC = 0.5).</p>♦<p>denotes p-value<0.001 relative to a random test (AUC = 0.5).</p><p>Bolded values denote AUC values significantly less than non-bolded values in a given row.</p><p>HB1, 2 = Hepatobiliary phase 1 and 2 (15 and 25 minutes post-contrast).</p><p>HCC = Hepatocellular carcinoma.</p><p>FNH = Focal Nodular Hyperplasia.</p
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
<p>The sensitivity and 1-specificity were plotted for each clinical feature, such as tumor multiplic...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
<p>These were used for identification of hepatocellular carcinoma (HCC), focal nodular hyperplasia (...
*<p>denotes a statistically significant (p<0.05) areas under the curve values relative to a random t...
<p>These reflect the ability to detect hepatocellular carcinoma (HCC), focal nodular hyperplasia (FN...
<p>ER – enhancement ratio.</p><p>CR – contrast ratio.</p><p>HB – hepatobiliary phase.</p><p>HCC = He...
<p><b>(</b>A) ROC curves for DKK1, TEMs and Logit<i>P</i>2 for the diagnosis of HCC versus all contr...
<p>Box-and-whisker plots showing the median (middle line of each box), quartiles (top and bottom lin...
<p>Areas under the curve (AUCs) estimated for the uc001ncr and AX800134 panel in the training cohort...
<p>The graph shows the temporal mean liver-to-lesion contrast (LLC) ratios of HCCs, metastases, aden...
<p>(A) ROC curves of the PFAA index in stage IIA (red), stage IIB (pink), stage III (orange), and st...
To assess the value of Hepatobiliary phase MRI (HPB-MRI) to differentiate FNH and HCA, and evaluate ...
<p>The graph shows the temporal mean contrast enhancement ratios (CERs) of HCCs, metastases, adenoma...
OBJECTIVE: To prospectively assess the additional value of the hepatobiliary (HB) phase of Gd-EOB-DT...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
<p>The sensitivity and 1-specificity were plotted for each clinical feature, such as tumor multiplic...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
<p>These were used for identification of hepatocellular carcinoma (HCC), focal nodular hyperplasia (...
*<p>denotes a statistically significant (p<0.05) areas under the curve values relative to a random t...
<p>These reflect the ability to detect hepatocellular carcinoma (HCC), focal nodular hyperplasia (FN...
<p>ER – enhancement ratio.</p><p>CR – contrast ratio.</p><p>HB – hepatobiliary phase.</p><p>HCC = He...
<p><b>(</b>A) ROC curves for DKK1, TEMs and Logit<i>P</i>2 for the diagnosis of HCC versus all contr...
<p>Box-and-whisker plots showing the median (middle line of each box), quartiles (top and bottom lin...
<p>Areas under the curve (AUCs) estimated for the uc001ncr and AX800134 panel in the training cohort...
<p>The graph shows the temporal mean liver-to-lesion contrast (LLC) ratios of HCCs, metastases, aden...
<p>(A) ROC curves of the PFAA index in stage IIA (red), stage IIB (pink), stage III (orange), and st...
To assess the value of Hepatobiliary phase MRI (HPB-MRI) to differentiate FNH and HCA, and evaluate ...
<p>The graph shows the temporal mean contrast enhancement ratios (CERs) of HCCs, metastases, adenoma...
OBJECTIVE: To prospectively assess the additional value of the hepatobiliary (HB) phase of Gd-EOB-DT...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...
<p>The sensitivity and 1-specificity were plotted for each clinical feature, such as tumor multiplic...
Ic (ROC) curve analysis. In figures 2A and 2B, corresponding to AFP and PIVKAII, the area under the ...